Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zenas BioPharma
Zenas BioPharma is developing immune-based therapies for autoimmune and rare diseases.
Biotech
BIO announces new CEO—Chutes & Ladders
BIO lands rare disease advocate John Crowley as CEO. Cyclerion Therapeutics picks EQRx leader for top spot. Sensorium selects new CEO.
Gabrielle Masson
,
Annalee Armstrong
Dec 8, 2023 9:30am
BMS pays Zenas $50M for some rights to ex-Xencor autoimmune drug
Sep 5, 2023 7:29am
Biogen taps new board chair—Chutes & Ladders
Mar 10, 2023 9:30am
Zenas zips up $118M series B to launch phase 3 trial
Nov 8, 2022 11:35am